<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AIndicative_offer_letter</id>
	<title>Definition:Indicative offer letter - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AIndicative_offer_letter"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Indicative_offer_letter&amp;action=history"/>
	<updated>2026-05-02T12:51:51Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Indicative_offer_letter&amp;diff=17667&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Indicative_offer_letter&amp;diff=17667&amp;oldid=prev"/>
		<updated>2026-03-15T15:34:14Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📝 &amp;#039;&amp;#039;&amp;#039;Indicative offer letter&amp;#039;&amp;#039;&amp;#039; is a preliminary, non-binding document submitted by a prospective acquirer expressing interest in purchasing an insurance company, [[Definition:Managing general agent (MGA) | MGA]], [[Definition:Book of business | book of business]], or other insurance asset, along with a proposed valuation range and key transaction terms. Often referred to as an indication of interest (IOI) or non-binding offer (NBO), this letter typically arrives after the buyer has reviewed an [[Definition:Information memorandum (IM) | information memorandum]] and initial data but before gaining access to a full [[Definition:Due diligence | due diligence]] data room. It serves as the buyer&amp;#039;s ticket to the next phase of a structured sale process, signaling serious intent and providing the seller with enough detail to compare competing bids.&lt;br /&gt;
&lt;br /&gt;
⚙️ A well-crafted indicative offer letter in an insurance context addresses several sector-specific dimensions beyond headline price. It outlines the buyer&amp;#039;s view on key actuarial assumptions — particularly the treatment of [[Definition:Loss reserve | reserves]] and any anticipated [[Definition:Purchase price adjustment | purchase price adjustments]] tied to [[Definition:Reserve development | reserve development]] — and indicates whether the proposed valuation is based on embedded value, a multiple of [[Definition:Gross written premium (GWP) | gross written premium]], book value, or another metric. The letter also addresses regulatory considerations, including the buyer&amp;#039;s plan for obtaining [[Definition:Change of control approval | change-of-control approvals]] from insurance regulators, anticipated timelines, and any conditions precedent such as securing [[Definition:Reinsurance | reinsurance]] or [[Definition:Financing | financing]]. Buyers frequently note their willingness (or lack thereof) to provide [[Definition:Indemnity cap | indemnity]] protections and describe the team and resources they will deploy for confirmatory due diligence.&lt;br /&gt;
&lt;br /&gt;
💡 For sellers — whether they are insurance groups divesting non-core units, [[Definition:Private equity | private equity]] sponsors exiting portfolio companies, or founders looking to monetize an [[Definition:Insurtech | insurtech]] platform — the indicative offer letter is the primary tool for sorting serious contenders from window-shoppers. Investment bankers running the process use these letters to create a shortlist of bidders who advance to detailed [[Definition:Due diligence | due diligence]] and management presentations. Because the letter is non-binding, its value lies not in legal enforceability but in the credibility of its terms: buyers who propose unrealistic valuations, vague regulatory strategies, or excessive conditionality risk being eliminated. In insurance M&amp;amp;A, where regulatory approval timelines can stretch for months and [[Definition:Actuarial due diligence | actuarial complexity]] adds layers of negotiation, a clear and well-informed indicative offer letter accelerates the process and sets the tone for the relationship between buyer and seller throughout the transaction.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Information memorandum (IM)]]&lt;br /&gt;
* [[Definition:Due diligence]]&lt;br /&gt;
* [[Definition:Letter of intent (LOI)]]&lt;br /&gt;
* [[Definition:Non-binding offer (NBO)]]&lt;br /&gt;
* [[Definition:Mergers and acquisitions (M&amp;amp;A)]]&lt;br /&gt;
* [[Definition:Change of control approval]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>